Viatris Inc. (VTRS) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

Key Points Company Overview 1. Company Name and Stock Symbol: Viatris Inc. (NASDAQ: VTRS) 2. Event: 43rd Annual J.P. Morgan Healthcare Conference 2025 3. Date and Time: January 14, 2025, 11:15 AM ET 4. Participants: - Scott Smith - CEO - Doretta Mistras - CFO - Philippe Martin - Chief R&D Officer - Corinne Le Goff - Chief Commercial Officer - Chris Schott - JPMorgan [1] Forward-Looking Statement 1. No Guidance Provided: The company will not be commenting on the full year 2024 or providing guidance for 2025 during the presentation. [2] Financial Highlights 1. Revenue: $15 billion in the last 12 months 2. Adjusted EBITDA: $4.8 billion in the last 12 months 3. Free Cash Flow: $2.4 billion in the last 12 months 4. Financial Strength: Viatris demonstrates tremendous financial strength [3] Business Segments 1. Global Generics Business: Strong global generics business 2. Iconic Brands: Home to iconic brands in the pharma world, including Lipitor, Lyrica, Celebrex, Norvasc, Viagra, etc. [3] Geographic Presence 1. Global Operations: Operates in 165 countries around the world [4]